Comment on:“A unique pseudo-eligibility analysis of longitudinal laboratory performance data from a transgender female competitive cyclist”  

作　　者：Tommy R.Lundberg Mary I.O’Connor Christopher Kirk Noel Pollock Gregory A.Brown 

机构地区：[1]Department of Laboratory Medicine,Division of Clinical Physiology,Karolinska Institutet,Stockholm,Sweden [2]Unit of Clinical Physiology,Karolinska University Hospital,Stockholm,Sweden [3]Mayo Clinic,Jacksonville,FL,USA [4]Sport and Physical Activity Research Centre,Sheffield Hallam University,Sheffield,UK [5]Institute of Sport,Exercise and Health,University College London,London,UK [6]Department of Kinesiology and Sport Sciences,University of Nebraska at Kearney,Kearney,NE,USA

出　　处：《Translational Exercise Biomedicine》2024年第3期355-358,共4页运动转化生物医学(英文)

摘　　要：Dear Editor,We are writing to express concerns regarding the recent paper“A unique pseudo-eligibility analysis of longitudinal laboratory performance data from a transgender female competitive cyclist”by Hamilton et al.[1].The authors assert that a sub-elite trans woman athlete can compete equitably in elite women’s cycling events after one year of gender-affirming hormone therapy(GAHT).However,this conclusion is not supported by the data presented.Furthermore,the authors’presentation of data from a single athlete as a basis for inferring the effects of testosterone suppression is fundamentally flawed.

关 键 词：gender COMPETITIVE ELITE 

分 类 号：H31[语言文字—英语]